1. 216 LIPOPOLYSACCHARIDE INHIBITS Fibroblast Growth Factor-10 EXPRESSION IN FETAL MOUSE LUNG MESENCHYME
- Author
-
Lawrence S. Prince, John T. Benjamin, R. Smith, and N. Davis
- Subjects
Pathology ,medicine.medical_specialty ,Lung ,FGF10 ,Mesenchyme ,Inflammation ,General Medicine ,respiratory system ,Biology ,medicine.disease ,General Biochemistry, Genetics and Molecular Biology ,Andrology ,medicine.anatomical_structure ,Real-time polymerase chain reaction ,Bronchopulmonary dysplasia ,Gene expression ,medicine ,medicine.symptom ,Signal transduction - Abstract
Purpose of Study Prenatal exposure to inflammation increases the risk of bronchopulmonary dysplasia (BPD) in preterm infants. In a fetal mouse lung model, lipopolysaccharide (LPS) decreased distal airway branching, which may contribute to BPD pathology. In a candidate gene approach, we tested if LPS decreased expression of FGF-10, a master regulator of branching morphogenesis. We hypothesized that decreased FGF-10 expression could lead to defective distal airway branching. Methods E16 fetal mouse lung explants were cultured for up to 72 hours. Distal airway branching was measured by counting the number of distal airways per explant area. Fetal mouse lung mesenchymal cells were also isolated and cultured. Gene expression was measured by real time PCR. Results We measured decreased FGF-10 gene expression in LPS-treated fetal lung explants (55% of control, p Conclusion LPS decreased FGF-10 expression and altered gene expression along the FGF-10 signaling pathway. Decreased FGF-10 expression may identify a mechanism by which innate immunity can contribute to BPD.
- Published
- 2006